Legal & General Group PLC Oncocyte Corp Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.86 - $1.53 $5,028 - $8,945	-5,847 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $3,702 - $6,178	-1,049 Reduced 15.21%	5,847 $21,000
Q2 2021 Aug 12, 2021	SELL	$3.77 - $6.0 $3,698 - $5,886	-981 Reduced 12.45%	6,896 $40,000
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $793 - $2,158	332 Added 4.4%	7,877 $41,000
Q3 2020 Nov 13, 2020	BUY	$1.2 - $1.89 $541 - $852	451 Added 6.36%	7,545 $10,000

Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $7,974 - $14,403	4,175 Added 143.03%	7,094 $14,000
Q1 2020 May 14, 2020	SELL	$1.76 - $3.02 $2,499 - $4,288	-1,420 Reduced 32.73%	2,919 $7,000
Q4 2019 Feb 13, 2020	BUY	$1.51 - $2.27 $1,152 - $1,732	763 Added 21.34%	4,339 $9,000
Q2 2019 Aug 14, 2019	BUY	$2.49 - $5.45 $8,904 - $19,489	3,576 New	3,576 $9,000
Q2 2018 Aug 10, 2018	SELL	$2.0 - $3.3 $768 - $1,267	-384 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.9 - $7.4 $1,497 - $2,841	384	384 $2,000

1.16M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $351M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.